24 results on '"Porte, Robert J."'
Search Results
2. Should donors and recipients be matched in liver transplantation?
- Author
-
Burra, Patrizia and Porte, Robert J.
- Published
- 2006
- Full Text
- View/download PDF
3. Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: What does the future have in store for us?
- Author
-
Lascaris, Bianca, de Meijer, Vincent E., and Porte, Robert J.
- Subjects
- *
PERFUSION , *LIVER transplantation , *LIVER , *STEM cell treatment , *LIVER regeneration - Abstract
Liver transplantation has become an immense success; nevertheless, far more recipients are registered on waiting lists than there are available donor livers for transplantation. High-risk, extended criteria donor livers are increasingly used to reduce the discrepancy between organ demand and supply. Especially for high-risk livers, dynamic preservation using machine perfusion can decrease post-transplantation complications and may increase donor liver utilisation by improving graft quality and enabling viability testing before transplantation. To further increase the availability of donor livers suitable for transplantation, new strategies are required that make it possible to use organs that are initially too damaged to be transplanted. With the current progress in experimental liver transplantation research, (long-term) normothermic machine perfusion may be used in the future as a dynamic platform for regenerative medicine approaches, enabling repair and regeneration of injured donor livers. Currently explored therapeutics such as defatting cocktails, RNA interference, senolytics, and stem cell therapy may assist in the repair and/or regeneration of injured livers before transplantation. This review will provide a forecast of the future utility of normothermic machine perfusion in decreasing the imbalance between donor liver demand and supply by enabling the repair and regeneration of damaged donor livers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Excellent long-term outcomes after sequential hypothermic and normothermic machine perfusion challenges the importance of functional donor warm ischemia time in DCD liver transplantation.
- Author
-
van Leeuwen, Otto B., Bodewes, Silke B., Porte, Robert J., and de Meijer, Vincent E.
- Subjects
- *
LIVER transplantation , *PERFUSION , *ISCHEMIA , *MACHINERY - Published
- 2023
- Full Text
- View/download PDF
5. A fetal wound healing program after intrauterine bile duct injury may contribute to biliary atresia.
- Author
-
de Jong, Iris E.M., Hunt, Mallory L., Chen, Dongning, Du, Yu, Llewellyn, Jessica, Gupta, Kapish, Li, David, Erxleben, Dorothea, Rivas, Felipe, Hall, Adam R., Furth, Emma E., Naji, Ali, Liu, Chengyang, Dhand, Abhishek, Burdick, Jason A., Davey, Marcus G., Flake, Alan W., Porte, Robert J., Russo, Pierre A., and Gaynor, J. William
- Subjects
- *
BILE ducts , *BILIARY atresia , *WOUND healing , *ACID deposition , *CHOLANGIOGRAPHY , *HYALURONIC acid , *FETAL surgery , *FETAL tissues - Abstract
Biliary atresia (BA) is an obstructive cholangiopathy that initially affects the extrahepatic bile ducts (EHBDs) of neonates. The etiology is uncertain, but evidence points to a prenatal cause. Fetal tissues have increased levels of hyaluronic acid (HA), which plays an integral role in fetal wound healing. The objective of this study was to determine whether a program of fetal wound healing is part of the response to fetal EHBD injury. Mouse, rat, sheep, and human EHBD samples were studied at different developmental time points. Models included a fetal sheep model of prenatal hypoxia, human BA EHBD remnants and liver samples taken at the time of the Kasai procedure, EHBDs isolated from neonatal rats and mice, and spheroids and other models generated from primary neonatal mouse cholangiocytes. A wide layer of high molecular weight HA encircling the lumen was characteristic of the normal perinatal but not adult EHBD. This layer, which was surrounded by collagen, expanded in injured ducts in parallel with extensive peribiliary gland hyperplasia, increased mucus production and elevated serum bilirubin levels. BA EHBD remnants similarly showed increased HA centered around ductular structures compared with age-appropriate controls. High molecular weight HA typical of the fetal/neonatal ducts caused increased cholangiocyte spheroid growth, whereas low molecular weight HA induced abnormal epithelial morphology; low molecular weight HA caused matrix swelling in a bile duct-on-a-chip device. The fetal/neonatal EHBD, including in human EHBD remnants from Kasai surgeries, demonstrated an injury response with prolonged high levels of HA typical of fetal wound healing. The expanded peri-luminal HA layer may swell and lead to elevated bilirubin levels and obstruction of the EHBD. Biliary atresia is a pediatric cholangiopathy associated with high morbidity and mortality rates; although multiple etiologies have been proposed, the fetal response to bile duct damage is largely unknown. This study explores the fetal pathogenesis after extrahepatic bile duct damage, thereby opening a completely new avenue to study therapeutic targets in the context of biliary atresia. [Display omitted] • Fetal and neonatal extrahepatic bile ducts have high levels of hyaluronic acid, located directly around the lumen. • Damage to the fetal extrahepatic bile duct is followed by increased hyaluronic acid deposition. • Biliary atresia remnants show increased hyaluronic acid deposition around epithelial structures compared to controls. • Hyaluronic acid in neonatal extrahepatic bile ducts is degraded after injury. • Hyaluronic acid polymers of different sizes have distinct biological effects on cholangiocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Platelet function in patients with cirrhosis
- Author
-
Lisman, Ton and Porte, Robert J.
- Published
- 2012
- Full Text
- View/download PDF
7. Recombinant factor VIIa to treat severe bleeding in patients with liver disease: Pitfalls and possibilities
- Author
-
Lisman, Ton and Porte, Robert J.
- Published
- 2011
- Full Text
- View/download PDF
8. Machine perfusion of the liver and bioengineering.
- Author
-
Schlegel, Andrea, Mergental, Hynek, Fondevila, Constantino, Porte, Robert J., Friend, Peter J., and Dutkowski, Philipp
- Subjects
- *
BIOENGINEERING , *PERFUSION , *LIVER , *LIVER cells , *INJURY complications , *KIDNEY transplantation - Abstract
With the increasing number of accepted candidates on waiting lists worldwide, there is an urgent need to expand the number and the quality of donor livers. Dynamic preservation approaches have demonstrated various benefits, including improving liver function and graft survival, and reducing liver injury and post-transplant complications. Consequently, organ perfusion techniques are being used in clinical practice in many countries. Despite this success, a proportion of livers do not meet current viability tests required for transplantation, even with the use of modern perfusion techniques. Therefore, devices are needed to further optimise machine liver perfusion – one promising option is to prolong machine liver perfusion for several days, with ex situ treatment of perfused livers. For example, stem cells, senolytics, or molecules targeting mitochondria or downstream signalling can be administered during long-term liver perfusion to modulate repair mechanisms and regeneration. Besides, today's perfusion equipment is also designed to enable the use of various liver bioengineering techniques, to develop scaffolds or for their re-cellularisation. Cells or entire livers can also undergo gene modulation to modify animal livers for xenotransplantation, to directly treat injured organs or to repopulate such scaffolds with "repaired" autologous cells. This review first discusses current strategies to improve the quality of donor livers, and secondly reports on bioengineering techniques to design optimised organs during machine perfusion. Current practice, as well as the benefits and challenges associated with these different perfusion strategies are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.
- Author
-
Schlegel, Andrea, Mueller, Matteo, Muller, Xavier, Eden, Janina, Panconesi, Rebecca, von Felten, Stefanie, Steigmiller, Klaus, Sousa Da Silva, Richard X., de Rougemont, Olivier, Mabrut, Jean-Yves, Lesurtel, Mickaël, Cerisuelo, Miriam Cortes, Heaton, Nigel D., Allard, Marc Antoine, Adam, Rene, Monbaliu, Diethard, Jochmans, Ina, Haring, Martijn P.D., Porte, Robert J., and Parente, Alessandro
- Subjects
- *
CLINICAL trials , *PERFUSION , *KIDNEY transplantation , *INTENSIVE care units , *LIVER , *LIVER transplantation - Abstract
Machine perfusion is a novel method intended to optimize livers before transplantation. However, its effect on morbidity within a 1-year period after transplantation has remained unclear. In this multicenter controlled trial, we randomly assigned livers donated after brain death (DBD) for liver transplantation (LT). Livers were either conventionally cold stored (control group), or cold stored and subsequently treated by 1-2 h hypothermic oxygenated perfusion (HOPE) before implantation (HOPE group). The primary endpoint was the occurrence of at least one post-transplant complication per patient, graded by the Clavien score of ≥III, within 1-year after LT. The comprehensive complication index (CCI), laboratory parameters, as well as duration of hospital and intensive care unit stay, graft survival, patient survival, and biliary complications served as secondary endpoints. Between April 2015 and August 2019, we randomized 177 livers, resulting in 170 liver transplantations (85 in the HOPE group and 85 in the control group). The number of patients with at least one Clavien ≥III complication was 46/85 (54.1%) in the control group and 44/85 (51.8%) in the HOPE group (odds ratio 0.91; 95% CI 0.50-1.66; p = 0.76). Secondary endpoints were also not significantly different between groups. A post hoc analysis revealed that liver-related Clavien ≥IIIb complications occurred less frequently in the HOPE group compared to the control group (risk ratio 0.26; 95% CI 0.07-0.77; p = 0.027). Likewise, graft failure due to liver-related complications did not occur in the HOPE group, but occurred in 7% (6 of 85) of the control group (log-rank test, p = 0.004, Gray test, p = 0.015). HOPE after cold storage of DBD livers resulted in similar proportions of patients with at least one Clavien ≥III complication compared to controls. Exploratory findings suggest that HOPE decreases the risk of severe liver graft-related events. This randomized controlled phase III trial is the first to investigate the impact of hypothermic oxygenated perfusion (HOPE) on cumulative complications within a 12-month period after liver transplantation. Compared to conventional cold storage, HOPE did not have a significant effect on the number of patients with at least one Clavien ≥III complication. However, we believe that HOPE may have a beneficial effect on the quantity of complications per patient, based on its application leading to fewer severe liver graft-related complications, and to a lower risk of liver-related graft loss. The HOPE approach can be applied easily after organ transport during recipient hepatectomy. This appears fundamental for wide acceptance since concurring perfusion technologies need either perfusion at donor sites or continuous perfusion during organ transport, which are much costlier and more laborious. We conclude therefore that the post hoc findings of this trial should be further validated in future studies. [Display omitted] • The number of patients with at least one Clavien ≥III complication was not significantly different between groups. • Severe post-transplant complications (Clavien grade IIIb or more), occurred less frequently in the HOPE-group. • This was caused by a 3.7-fold lower number of liver-related Clavien ≥IIIb complications per patient in the HOPE-group. • Graft failure due to liver-related complications did not occur in the HOPE-group but occurred in 7% in the control-group. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions.
- Author
-
Weeder, Pepijn D., van Rijn, Rianne, and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *SURGICAL anastomosis , *DISEASE incidence , *ETIOLOGY of diseases , *BILE ducts , *MESENCHYMAL stem cells , *WOUNDS & injuries - Abstract
Summary The high incidence of non-anastomotic biliary strictures (NAS) after transplantation of livers from extended criteria donors is currently a major barrier to widespread use of these organs. This review provides an update on the most recent advances in the understanding of the etiology of NAS. These new insights give reason to believe that machine perfusion can reduce the incidence of NAS after transplantation by providing more protective effects on the biliary tree during preservation of the donor liver. An overview is presented regarding the different endpoints that have been used for assessment of biliary injury and function before and after transplantation, emphasizing on methods used during machine perfusion. The wide spectrum of different approaches to machine perfusion is discussed, including the many different combinations of techniques, temperatures and perfusates at varying time points. In addition, the current understanding of the effect of machine perfusion in relation to biliary injury is reviewed. Finally, we explore directions for future research such as the application of (pharmacological) strategies during machine perfusion to further improve preservation. We stress the great potential of machine perfusion to possibly expand the donor pool by reducing the incidence of NAS in extended criteria organs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?
- Author
-
Karimian, Negin, op den Dries, Sanna, and Porte, Robert J.
- Published
- 2013
- Full Text
- View/download PDF
12. The heterogeneity of the biliary tree.
- Author
-
de Jong, Iris E.M., van den Heuvel, Marius C., Wells, Rebecca G., and Porte, Robert J.
- Subjects
- *
BILIARY tract , *HETEROGENEITY , *BILE ducts - Published
- 2021
- Full Text
- View/download PDF
13. Is single portal vein perfusion the best approach for machine preservation of liver grafts?
- Author
-
Brüggenwirth, Isabel M.A., Burlage, Laura C., Porte, Robert J., and Martins, Paulo N.
- Subjects
- *
PORTAL vein , *PERFUSION , *PRESERVATION of organs, tissues, etc. - Abstract
A letter to the editor is presented in response to the article "Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?" by A. Schlegel and colleagues.
- Published
- 2016
- Full Text
- View/download PDF
14. The role of platelets in liver regeneration – What don’t we know?
- Author
-
Lisman, Ton, Kirschbaum, Marc, and Porte, Robert J.
- Subjects
- *
LIVER regeneration , *BLOOD platelets , *HEPATOLOGY , *MEDICAL periodicals , *PUBLISHING - Published
- 2015
- Full Text
- View/download PDF
15. Anemia as a potential contributor to bleeding in patients with liver disease – Neglected but not forgotten
- Author
-
Lisman, Ton, Caldwell, Stephen H., and Porte, Robert J.
- Published
- 2011
- Full Text
- View/download PDF
16. Preservation injury of the distal extrahepatic bile duct of donor livers is representative for injury of the intrahepatic bile ducts.
- Author
-
Karimian, Negin, Weeder, Pepijn D., Bomfati, Fernanda, Gouw, Annette S.H., and Porte, Robert J.
- Subjects
- *
BILE ducts , *ORGAN donation , *LIVER necrosis , *LIVER histology , *LIVER biopsy , *WOUNDS & injuries - Published
- 2015
- Full Text
- View/download PDF
17. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures.
- Author
-
op den Dries, Sanna, Westerkamp, Andrie C., Karimian, Negin, Gouw, Annette S.H., Bruinsma, Bote G., Markmann, James F., Lisman, Ton, Yeh, Heidi, Uygun, Korkut, Martins, Paulo N., and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *BILE ducts , *PROGENITOR cells , *OPERATIVE surgery , *SURGICAL complications , *DISEASE progression , *COMPARATIVE studies , *WOUNDS & injuries - Abstract
Background & Aims: The peribiliary glands of large bile ducts have been identified as a niche of progenitor cells that contribute to regeneration of biliary epithelium after injury. We aimed to determine whether injury to the peribiliary glands of donor livers is a risk factor for development of non-anastomotic biliary strictures (NAS) after liver transplantation. Methods: In 128 liver transplant procedures, biopsies were taken from the donor bile duct and injury was assessed using an established histological grading system. Histological severity of injury was subsequently compared in liver grafts that later developed biliary structures vs. uncomplicated liver grafts. Results: Luminal biliary epithelial loss >50% was observed in 91.8% of the grafts before transplantation, yet NAS occurred in only 16.4%. Periluminal peribiliary glands were more severely injured than deep peribiliary glands located near the fibromuscular layer (>50% loss in 56.9% vs. 17.5%, respectively; p <0.001). Injury of deep peribiliary glands was more prevalent and more severe in livers that later developed NAS, compared to grafts without NAS (>50% loss in 50.0% vs. 9.8%, respectively; p =0.004). In parallel, injury of the peribiliary vascular plexus was more severe in livers that developed NAS, compared to grafts without NAS (>50% vascular changes in 57.1% vs. 20.3%; p =0.006). Conclusion: Injury of peribiliary glands and vascular plexus before transplantation is strongly associated with the occurrence of biliary strictures after transplantation. This suggests that insufficient regeneration due to loss of peribiliary glands or impaired blood supply may explain the development of biliary strictures. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
18. Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats.
- Author
-
Lisman, Ton, Kamphuisen, Pieter W., Northup, Patrick G., and Porte, Robert J.
- Subjects
- *
TREATMENT of cirrhosis of the liver , *FIBRINOLYTIC agents , *HEMORRHAGE , *THROMBOSIS , *PULMONARY embolism , *CEREBROVASCULAR disease - Abstract
Summary: Until recently, it was widely accepted that patients with cirrhosis have a bleeding tendency related to the changes in the hemostatic system that occur as a consequence of the disease. However, it has now been well established that patients with cirrhosis are at risk for both bleeding and thrombotic complications. These thrombotic complications include portal vein thrombosis, deep vein thrombosis and pulmonary embolism, and coronary or cerebrovascular infarctions. Antithrombotic drugs to prevent or treat thrombotic complications in patients with cirrhosis have been used only minimally in the past due to the perceived bleeding risk. As the thrombotic complications and the necessity of antithrombotic treatment in these patients are increasingly recognized, the use of antithrombotic drugs in this population is likely increasing. Moreover, given the rising incidence of fatty liver disease and generally longer survival times of patients with chronic liver diseases, it would be reasonable to presume that some of these thrombotic complications may be increasing in incidence over time. In this review, we will outline the indications for antithrombotic treatment in patients with cirrhosis. Furthermore, we will discuss the available antithrombotic drugs and indicate possible applications, advantages, and caveats. Since for many of these drugs very little experience in patients with cirrhosis exists, these data are essential in the design of future clinical and laboratory studies on mechanisms, efficacy, and safety of the various antithrombotic strategies in these patients. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
19. Mannose-binding lectin and Ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation
- Author
-
de Rooij, Bert-Jan F., van der Beek, Martha T., van Hoek, Bart, Vossen, Ann C.T.M., Rogier ten Hove, W., Roos, Anja, Schaapherder, Alexander F., Porte, Robert J., van der Reijden, Johan J., Coenraad, Minneke J., Hommes, Daniel W., and Verspaget, Hein W.
- Subjects
- *
LIVER transplantation , *COMPLICATIONS from organ transplantation , *GENETIC polymorphisms , *CYTOMEGALOVIRUS diseases , *NATURAL immunity , *SERINE proteinases , *GENE frequency , *LECTINS - Abstract
Background & Aims: The lectin pathway of complement activation is a crucial effector cascade of the innate immune response to pathogens. Cytomegalovirus (CMV) infection occurs frequently in immunocompromised patients after orthotopic liver transplantation (OLT). Single-nucleotide polymorphisms (SNPs) in the lectin pathway genes determine their liver-derived protein level and functional activity. We examined the association between these SNPs and the risk for CMV infection in OLT. Methods: OLT patients (n =295) were genotyped for recipient and donor SNPs in mannose-binding lectin (MBL2), Ficolin-2 (FCN2) and MBL-associated serine protease (MASP2) genes. Results: Combined analysis of independently associated variant MBL2 [HR 1.65, p <0.02] and wild-type FCN2 [1.85; p <0.02] SNPs in the donor liver showed an increased risk of CMV infection for either and both risk genotypes [HR 2.02 and HR 3.26, respectively, p =0.004], especially in CMV Donor−/Recipient+ (D−/R+) patients [HR 4.7 and HR 10.0, respectively, p =0.01]. A genetic donor–recipient mismatch for MBL2 and FCN2 increased the CMV risk independently, also combined [HR 5.35; p <0.001], particularly in CMV D−/R+ patients [HR 16.6; p =0.009]. Multivariate Cox analysis showed a consistent stepwise increase in CMV infection risk with the gene profile of the donor [up to HR 2.77; p <0.005] and the combined MBL2 and FCN2 donor–recipient mismatch profile [up to HR 4.57; p <0.001], independent from donor–recipient CMV serostatus, also at higher CMV (re)infection cut-off values. Conclusions: MBL2 and FCN2 risk alleles of donor liver and recipient constitute independent risk factors for CMV infection after OLT. Patients with these risk genes probably need intensified CMV monitoring and anti-viral therapy. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
20. Hemostasis and thrombosis in patients with liver disease: The ups and downs
- Author
-
Lisman, Ton, Caldwell, Stephen H., Burroughs, Andrew K., Northup, Patrick G., Senzolo, Marco, Stravitz, R. Todd, Tripodi, Armando, Trotter, James F., Valla, Dominique-Charles, and Porte, Robert J.
- Subjects
- *
LIVER diseases , *HEMOSTASIS , *THROMBOSIS , *LIVER failure , *BLOOD coagulation tests , *INTRACRANIAL pressure , *HEMORRHAGE , *PATIENTS - Abstract
Abstract: Patients with chronic or acute liver failure frequently show profound abnormalities in their hemostatic system. Whereas routine laboratory tests of hemostasis suggest these hemostatic alterations result in a bleeding diathesis, accumulating evidence from both clinical and laboratory studies suggest that the situation is more complex. The average patient with liver failure may be in hemostatic balance despite prolonged routine coagulation tests, since both pro- and antihemostatic factors are affected, the latter of which are not well reflected in routine coagulation testing. However, this balance may easily tip towards a hypo- or hypercoagulable situation. Indeed, patients with liver disease may encounter both hemostasis-related bleeding episodes as well as thrombotic events. During the 3rd International Symposium on Coagulopathy and Liver disease, held in Groningen, The Netherlands (18–19 September 2009), a multidisciplinary panel of experts critically reviewed the current data concerning pathophysiology and clinical consequences of hemostatic disorders in patients with liver disease. Highlights of this symposium are summarized in this review. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
21. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests
- Author
-
Lisman, Ton, Bakhtiari, Kamran, Pereboom, Ilona T.A., Hendriks, Herman G.D., Meijers, Joost C.M., and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *THROMBIN , *BLOOD coagulation , *THROMBOMODULIN , *ANTICOAGULANTS , *BLOOD plasma - Abstract
Background & Aims: Patients with liver disease often show substantial changes in their hemostatic system, which may aggravate further during liver transplantation. Recently, thrombin generation in patients with stable disease was shown to be indistinguishable from controls provided thrombomodulin, the natural activator of the anticoagulant protein C system, was added to the plasma. These results indicated that the hemostatic balance is preserved in patients with liver disease, despite conventional coagulation tests suggest otherwise. Methods: Here we examined thrombin generation profiles in serial plasma samples taken from ten consecutive patients undergoing liver transplantation. Results: At all time points, the endogenous thrombin potential (ETP) was slightly lower compared to healthy volunteers, despite substantially prolonged PT and APTT values. However, when thrombin generation was tested in the presence of thrombomodulin, the ETP was equal to or even higher than that in healthy subjects. In fact, thrombin generation was hardly affected by thrombomodulin, while thrombin generation in healthy subjects decreased profoundly upon the addition of thrombomodulin. In patients undergoing liver transplantation, efficient thrombin generation in the presence of thrombomodulin may be explained by decreased levels of protein C, S, and antithrombin, and by elevated levels of FVIII. Conclusions: Thrombin generation in patients undergoing liver transplantation is equal or even superior to thrombin generation in healthy volunteers when tested in the presence of exogenous thrombomodulin. These results support the recently advocated restrictive use of plasma during liver transplantation and warrants further study of the prophylactic use of anticoagulants to reduce thromboembolic complications after transplantation. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
22. Who should get a liver graft?
- Author
-
Freeman, Richard B., Jamieson, Neville, Schaubel, Douglas E., Porte, Robert J., and Villamil, Federico G.
- Published
- 2009
- Full Text
- View/download PDF
23. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures
- Author
-
Buis, Carlijn I., Geuken, Erwin, Visser, Dorien S., Kuipers, Folkert, Haagsma, Elizabeth B., Verkade, Henkjan J., and Porte, Robert J.
- Subjects
- *
COMPLICATIONS from organ transplantation , *LIVER transplantation , *BILE duct abnormalities , *SURGICAL complications , *MEDICAL care , *PHOSPHOLIPIDS , *BILE salts , *THERAPEUTICS - Abstract
Background/Aims: Nonanastomotic biliary strictures are troublesome complications after liver transplantation. The pathogenesis of NAS is not completely clear, but experimental studies suggest that bile salt toxicity is involved. Methods: In one hundred and eleven adult liver transplants, bile samples were collected daily posttransplantation for determination of bile composition. Expression of bile transporters was studied perioperatively. Results: Nonanastomotic biliary strictures were detected in 14 patients (13%) within one year after transplantation. Patient and donor characteristics and postoperative serum liver enzymes were similar between patients who developed nonanastomotic biliary strictures and those who did not. Secretions of bile salts, phospholipids and cholesterol were significantly lower in patients who developed strictures. In parallel, biliary phospholipids/bile salt ratio was lower in patients developing strictures, suggestive for increased bile cytotoxicity. There were no differences in bile salt pool composition or in hepatobiliary transporter expression. Conclusions: Although patients who develop nonanastomotic biliary strictures are initially clinically indiscernible from patients who do not develop nonanastomotic biliary strictures, the biliary bile salts and phospholipids secretion, as well as biliary phospholipids/bile salt ratio in the first week after transplantation, was significantly lower in the former group. This supports the concept that bile cytotoxicity is involved in the pathogenesis of nonanastomotic biliary strictures. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
24. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation
- Author
-
Geuken, Erwin, Visser, Dorien, Kuipers, Folkert, Blokzijl, Hans, Leuvenink, Henri G.D., de Jong, Koert P., Peeters, Paul M.J.G., Jansen, Peter L.M., Slooff, Maarten J.H., Gouw, Annette S.H., and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *BILE ducts , *ALKALINE phosphatase , *MESSENGER RNA - Abstract
Background/Aims: Biliary strictures are a serious cause of morbidity after liver transplantation. We have studied the role of altered bile composition as a mechanism of bile duct injury after human liver transplantation. Methods: In 28 liver transplant recipients, bile samples were collected daily posttransplantation for determination of bile composition. Hepatic expression of bile transporters was studied before and after transplantation. Histopathological criteria as well as biliary concentrations of alkaline phosphatase (ALP) and γ-glutamyltransferase (γ-GT) were used to quantify bile duct injury. Results: Early after transplantation, bile salt secretion increased more rapidly than phospholipid secretion, resulting in high biliary bile salt/phospholipid ratio (BA/PL). In parallel with this, mRNA levels of the bile salt transporters NTCP and BSEP increased significantly after transplantation, whereas phospholipid translocator MDR3 mRNA levels remained unchanged. Bile duct injury correlated significantly with bile salt secretion and was associated with a high biliary BA/PL ratio. Conclusions: Bile salt secretion after human liver transplantation recovers more rapidly than phospholipid secretion. This results in cytotoxic bile formation and correlates with bile duct injury. These findings suggest that endogenous bile salts have a role in the pathogenesis of bile duct injury after liver transplantation. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.